drugset / Trial / NCT06564961

Clomiphene Citrate in Infertile Men With Idiopathic Oligoasthenozoospermia

NCT06564961

Phase 3 Completed 50 enrolled Shakeela Ishrat
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this clinical trial is to learn if drug clomiphene citrate improves sperm parameters in infertile men with idiopathic oligoasthenozoospermia. It will also learn about the safety of clomiphene citrate. The main questions it aims to answer are: * Does drug clomiphene citrate change sperm count and motility in infertile men with idiopathic oligoasthenozoospermia? * What medical problems do participants have when taking drug clomiphene citrate? Researchers will compare drug clomiphene citrate to a placebo (a look-alike substance that contains no drug) to see if drug clomiphene citrate works to treat idiopathic oligoasthenozoospermia.

Timeline

Start
2022-07-01
Primary completion
2023-06-30
Completion
2023-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Clomiphene Other / unclassified 50 mg Oral

Indications